Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 17/20 | 0.81 |
| ▸ | PTGDR | Q13258 | 8/20 | 0.81 |
| ▸ | PTGER2 | P43116 | 2/20 | 0.81 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.81 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.81 |
| ▸ | PTGFR | P43088 | 1/20 | 0.81 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.81 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.40 |
| ▸ | KLK1 | P06870 | 1/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.40 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.40 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.40 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.40 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10019030 | 0.90 | PTGER4 (0.68) | PTGER4PTGDRPTGER2TBXA2RPTGER1 | |
| SCHEMBL10019022 | 0.90 | PTGER4 (0.67) | PTGER4PTGDRPTGER2TBXA2RPTGER1 | |
| SCHEMBL2109484 | 0.90 | PTGER4 (1.00) | PTGER4PTGDRPTGER2TBXA2RPTGER1 | |
| SCHEMBL29517904 | 0.90 | PTGER4 (1.00) | PTGER4PTGDRPTGER2TBXA2RPTGER1 | |
| Diethylamine SCHEMBL2110430 | 0.85 | PTGER4 (0.90) | PTGER4PTGDRPTGER2TBXA2RPTGER1 | |
| SCHEMBL2110525 | 0.80 | PTGER4 (0.82) | PTGER4PTGDRPTGER2TBXA2RPTGER1 | |
| SCHEMBL10019024 | 0.80 | PTGER4 (0.76) | PTGER4PTGDRPTGER2TBXA2RPTGER1 | |
| SCHEMBL14312286 | 0.79 | PTGER4 (0.75) | PTGER4PTGDRPTGER2TBXA2RPTGER1 | |
| SCHEMBL30553059 | 0.79 | PTGER4 (0.70) | PTGER4PTGDRPTGER2TBXA2RPTGER1 | |
| SCHEMBL31366898 | 0.79 | PTGER4 (0.80) | PTGER4PTGDRPTGER2TBXA2RPTGER1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2114877-B1 | INDOLE AND INDOLINE CYCLOPROPYL AMIDE DERIVATIVES AS EP4 RECEPTOR ANTAGONISTS | MERCK CANADA INC (CA) | 2012-12-26 | — | — | EP | disclosed |
| US-8158671-B2 | Indole and indoline cyclopropyl amide derivatives as EP4 receptor antagonists | MERCK CANADA INC. (CA) | 2012-04-17 | — | — | US | disclosed |
| US-20090318518-A1 | INDOLE AND INDOLINE CYCLOPROPYL AMIDE DERIVATIVES AS EP4 RECEPTOR ANTAGONISTS | MERCK CANADA INC. (CA) | 2009-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090318518-A1 | INDOLE AND INDOLINE CYCLOPROPYL AMIDE DERIVATIVES AS EP4 RECEPTOR ANTAGONISTS | PTGER4, PTGER1, PTGER3 | PTGER4 1/4885PTGDR 10/4885PTGER2 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.